Microbot Medical (MBOT) Financials

$1.44

$0.00 (0.00%)

As on 04-Sep-2026 16:26EDT

Market cap

$97 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.35	--	--	--	--	--
Cost of Revenue	1.01	0.05	0.09	0.11	0.10	0.08
Gross Profit	-0.66	-0.05	-0.09	-0.11	-0.10	-0.08
Operating Expenses	17.87	14.74	11.53	9.75	13.28	11.36
Operating Profit (EBIT)	-18.51	-14.74	-11.63	-9.86	-13.28	-11.36
Other Income	--	--	--	--	--	--
Profit before Tax	-16.34	-13.14	-11.44	-10.74	-13.17	-11.31
Provision for Tax	--	--	0.18	--	-118.00	-0.04
Profit after Tax (Net Income)	-16.34	-13.14	-11.44	-10.74	-13.17	-11.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-13.17	-11.31

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	68.93	77.55	3.53	4.50	7.29	14.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.55	0.57	0.04	0.04	0.18	0.40
Current Liabilities	3.89	3.42	2.46	3.79	2.07	1.98
Total Liabilities	77.25	81.54	6.03	8.33	9.54	16.77

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.19	1.72	0.21	0.41	0.72	0.89
Current Assets	72.17	79.82	5.82	7.92	8.81	15.88
Total Assets	145.54	81.54	6.03	8.33	9.54	16.77
Total Debt*	0.88	0.87	0.11	0.23	0.46	0.68
Net Current Assets	--	76.40	3.36	4.14	6.75	13.90

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13.05	-8.83	-8.53	-11.55	-9.35
Cash Flow from Investing Activities	--	-72.38	1.54	1.97	-3.84	3.20
Cash from Financing Activities	--	86.24	7.94	6.56	4.32	4.32
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.26	-0.20	-0.67	-0.89	-1.71	-1.59
Cash EPS ($)	-0.25	-0.19	-0.67	-0.88	-1.69	-1.58
Adjusted Book Value ($)	1.03	1.15	0.21	0.37	0.94	2.02
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.19	-0.52	-0.70	-1.50	-1.32
Free Cash Flow per Share ($)	--	-0.20	-0.52	-0.71	-1.51	-1.33

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-32.03	-273.33	-172.07	-115.45	-56.31
ROE (%)	-22.31	-32.42	-284.97	-182.19	-121.53	-58.48
ROA (%)	-18.01	-30.01	-159.40	-120.24	-100.12	-52.56
EBIT Margin (%)	-4,722.25	--	--	--	--	--
Net Margin (%)	-4,722.25	--	--	--	--	--
Cash Profit Margin (%)	-0.15	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	311.90	--	--	--	--	--
EBIT Growth (%)	-28.57	-14.85	-6.55	20.07	-18.77	-24.47
Net Profit Growth (%)	-28.57	-14.85	-6.55	18.44	-16.40	-23.38
EPS Growth (%)	58.90	0.71	0.24	0.48	-0.07	-0.23
Book Value Growth (%)	23.35	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-10.22	-1.67	-1.85	-1.76	-4.71
Price / Book Value	1.44	1.73	5.40	4.42	3.19	3.71
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.89	-4.32	-1.21	-1.29	-1.16	-3.43
Close Price ($)	1.95	2.00	1.12	1.64	3.01	7.50
High Price ($)	4.67	4.67	2.35	4.37	9.25	10.69
Low Price ($)	1.60	1.11	0.82	1.00	3.00	4.31
Market Cap ($ Cr)	96.72	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.03	0.05	0.06	0.05
Short term debt to equity ratio	0.00	0.00	0.02	0.04	0.04	0.02
Current Ratio	18.56	23.33	2.37	2.09	4.26	8.00
Quick Ratio	17.82	23.16	2.37	2.10	4.31	8.09
Interest Coverage	--	--	--	--	-0.10	-257.11

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	50.87	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	2,269.21	-84.29	-249.82	-495.95	-430.13
Payable days	--	2,626.69	1,047.59	814.92	707.22	1,331.24
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.